Month: September 2020

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2020.09.29

Genomtec S.A. presents its flagship diagnostic platform – Genomtec ID

Work on the mobile diagnostic platform – Genomtec ID, began in 2017 and currently we are starting its industrialization, proudly presenting ...
Read
2020.09.25

Genomtec S.A. is being strengthened by joining key personnel – welcome to Jarek Oleszczuk, M.D., PhD, Marta Gajęcka and Jakub Swadźba, M.D., PhD.

Due to the dynamic growth in space the of company’s flagship project – Genomtec ID, the Management Board, fulfilling expectations of its ...
Read

Archive